+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ambu AS (AMBU B) - Product Pipeline Analysis, 2023 Update

  • PDF Icon

    Company Profile

  • 42 Pages
  • November 2023
  • GlobalData
  • Ambu
  • ID: 5509110
Ambu A/S (Ambu) is a medical device company that manufactures and markets life supporting devices. It focuses on single-use devices for anesthesia, endoscopy, cardiology, patient monitoring and diagnostics and emergency care. It serves hospitals, clinics, sleep laboratories and rescue services. The company's product portfolio includes ventilation products for artificial respiration, resuscitators, single-use videoscopes, electrodes for ECG tests and neurophysiological tests, and manikins for first aid training. Ambu sells its medical devices through direct sales force and a network of distributors to hospitals and ambulances worldwide and operates offices in North America, Europe and Asia-Pacific. It has production facilities in China, Malaysia, and the US. Ambu is headquartered in Ballerup, Denmark.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Ambu AS
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Ambu A/S Company Overview
  • Ambu A/S Company Snapshot
  • Ambu A/S Pipeline Products and Ongoing Clinical Trials Overview
  • Ambu A/S - Pipeline Analysis Overview
  • Business Description
  • Ambu A/S - Key Facts
  • Ambu A/S - Major Products and Services
  • Ambu A/S Pipeline Products by Development Stage
  • Ambu A/S Pipeline Products Overview
  • Scope 5 - Selected Procedures
  • Scope 5 - Selected Procedures Product Overview
  • Scope 5 - Smaller Patients
  • Scope 5 - Smaller Patients Product Overview
  • Scope 5 Cysto HD
  • Scope 5 Cysto HD Product Overview
  • Scope Colon
  • Scope Colon Product Overview
  • Scope Duodeno 2.0
  • Scope Duodeno 2.0 Product Overview
  • Cholangioscope
  • Cholangioscope Product Overview
  • Colonoscope
  • Colonoscope Product Overview
  • Cystoscope HD
  • Cystoscope HD Product Overview
  • ENT Fees
  • ENT Fees Product Overview
  • High-Resolution ENTscope
  • High-Resolution ENTscope Product Overview
  • High-Resolution Rhinolaryngoscope
  • High-Resolution Rhinolaryngoscope Product Overview
  • Ureteroscope
  • Ureteroscope Product Overview
  • Video Laryngoscope 2.0
  • Video Laryngoscope 2.0 Product Overview
  • Ambu A/S - Key Competitors
  • Ambu A/S - Key Employees
  • Ambu A/S - Key Employee Biographies
  • Ambu A/S - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Ambu A/S, Recent Developments
  • Nov 17, 2023: Ambu Notice for the Annual General Meeting
  • Oct 11, 2023: Ambu Appoints New Chief Financial Officer
  • Oct 11, 2023: Ambu Receives 510(K) Clearance For Ambu Scope 5 Broncho 4.2/2.2 Sampler Set
  • Oct 09, 2023: Ambu Announces Preliminary Financial Results For The Fiscal Year 2022/23
  • Oct 02, 2023: Ambu Obtains Additional 510(k) Clearance for Ambu ABox 2
  • Aug 23, 2023: Ambu Receives 510(k) Clearance for Ambu Scope 5 Broncho 2.7/1.2
  • Aug 23, 2023: Ambu Receives 510(k) Clearance for Ambu Scope 5 Broncho 4.2/2.2
  • Aug 22, 2023: Ambu Receives Additional 510(k) clearance for Ambu ABox 2
  • Jun 16, 2023: Ambu Receives 510(k) Clearance for Ambu aView 2 Advance
  • Feb 07, 2023: Ambu Announces Interim Report For Q1 2022/23
  • Appendix
  • Methodology
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Ambu A/S Pipeline Products and Ongoing Clinical Trials Overview
  • Ambu A/S Pipeline Products by Equipment Type
  • Ambu A/S Pipeline Products by Indication
  • Ambu A/S, Key Facts
  • Ambu A/S, Major Products and Services
  • Ambu A/S Number of Pipeline Products by Development Stage
  • Ambu A/S Pipeline Products Summary by Development Stage
  • Scope 5 - Selected Procedures - Product Status
  • Scope 5 - Selected Procedures - Product Description
  • Scope 5 - Smaller Patients - Product Status
  • Scope 5 - Smaller Patients - Product Description
  • Scope 5 Cysto HD - Product Status
  • Scope 5 Cysto HD - Product Description
  • Scope Colon - Product Status
  • Scope Colon - Product Description
  • Scope Duodeno 2.0 - Product Status
  • Scope Duodeno 2.0 - Product Description
  • Cholangioscope - Product Status
  • Cholangioscope - Product Description
  • Colonoscope - Product Status
  • Colonoscope - Product Description
  • Cystoscope HD - Product Status
  • Cystoscope HD - Product Description
  • ENT Fees - Product Status
  • ENT Fees - Product Description
  • High-Resolution ENTscope - Product Status
  • High-Resolution ENTscope - Product Description
  • High-Resolution Rhinolaryngoscope - Product Status
  • High-Resolution Rhinolaryngoscope - Product Description
  • Ureteroscope - Product Status
  • Ureteroscope - Product Description
  • Video Laryngoscope 2.0 - Product Status
  • Video Laryngoscope 2.0 - Product Description
  • Ambu A/S, Key Employees
  • Ambu A/S, Key Employee Biographies
  • Ambu A/S, Subsidiaries
  • Glossary
List of Figures
  • Ambu A/S Pipeline Products by Equipment Type
  • Ambu A/S Pipeline Products by Development Stage

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Mermaid Care A/S
  • Hill-Rom Holdings Inc
  • Boston Scientific Corp
  • Teleflex Inc
  • Laerdal Medical AS
  • Lohmann & Rauscher GmbH & Co. KG
  • KARL STORZ SE & Co KG